RYCHELLE MAGRIBY: Open Payments
NPI 1366041873 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 25 payments from 11 companies in 2025. Trend: 2023 $207 · 2024 $644 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $247 |
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| E.R. Squibb & Sons, L.L.C. | 2 | $90 |
| SCPHARMACEUTICALS INC. | 5 | $86 |
| Amgen Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $30 |
| HEARTFLOW, INC. | 1 | $30 |
| Edwards Lifesciences Corporation | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
Products named: Kerendia, LEQVIO, CAMZYOS, FUROSCIX, REPATHA, Wegovy, FFRct, SAPIEN 3 Ultra RESILIA.
Industry payments across GA — which companies pay providers there.
